Scientific presentation Scientific presentation Expert talks and scientific presentations by local and international clinicians and scientists. Published: Dec 19, 2022

Meeting the therapeutic challenge of Huntington’s disease

Professor Sarah Tabrizi discusses how we can address the challenges to effective treatment of Huntington's disease. 

Sarah Tabrizi has undertaken consultancy services for Alnylam Pharmaceuticals Inc., Atalanta Pharmaceuticals, F. Hoffmann-La Roche Ltd, Genentech, Guidepoint, Horama, Locanobio, LoQus23 Therapeutics Ltd, Novartis Pharma, PTC Therapeutics, Sanofi, Spark Therapeutics, Takeda Pharmaceuticals Ltd, Triplet Therapeutics, University College Irvine and Vertex Pharmaceuticals Incorporated.

Learn more

Movement Disorders Dementia Genetics Huntington's disease antisense oligonucleotides tominersen small-molecule splicing modulators huntingtin protein gene therapy